Growth and growth biomarker changes after adenotonsillectomy: systematic review and meta-analysis

K A Bonuck1, K Freeman, J Henderson

  • 1Department of Family and Social Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Mazer, Bronx, NY 10461, USA. bonuck@montefiore.org

Insights

Adenotonsillectomy significantly improves growth and growth biomarkers in children with sleep disordered breathing (SDB). This suggests SDB should be considered in cases of childhood growth failure.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Surgical Outcomes

Background:

  • Sleep disordered breathing (SDB) in children, often caused by enlarged adenoids and tonsils, is linked to impaired growth.
  • Growth failure in children can be exacerbated by SDB, necessitating investigation into effective treatments.

Purpose of the Study:

  • To evaluate the impact of adenoidectomy and/or tonsillectomy (adenotonsillectomy) on growth and key growth biomarkers in children with SDB.
  • To determine if surgical intervention for SDB improves anthropometric measurements and serum levels of IGF-1 and IGFBP-3.

Main Methods:

  • A systematic review and meta-analysis of observational studies published between January 1980 and November 2007.
  • Searched PubMed, ERIC, and Cochrane Reviews for studies reporting pre/post-adenotonsillectomy changes in height, weight, IGF-1, and IGFBP-3 in children.
  • Included studies with available z scores or centiles for anthropometrics and serum levels.

Main Results:

  • Meta-analysis of 20 studies involving 363-390 children showed significant post-adenotonsillectomy increases.
  • Pooled standardized mean differences (SMD) indicated improvements in standardized height (SMD=0.34) and weight (SMD=0.57).
  • Significant increases were also observed in IGF-1 (SMD=0.53) and IGFBP-3 (SMD=0.59) levels.

Conclusions:

  • Adenotonsillectomy leads to significant improvements in standardized height, weight, and growth biomarkers (IGF-1, IGFBP-3).
  • Healthcare providers should consider SDB due to adenotonsillar hypertrophy in the evaluation and management of children experiencing growth failure.
Abstract